Magle Chemoswed Holding ABOSTO:MAGLE -3.85%38 Days Payable is 438.76 as of Mar. 2026, which is 80% above its 10-year median of 243.23. GuruFocus rates OSTO:MAGLE with a GF Score™ of 38/100 and a GF Value™ of kr23.19 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 702 Biotechnology companies, Magle Chemoswed Holding AB ranks better than 69.52% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:MAGLE vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Magle Chemoswed Holding AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Magle Chemoswed Holding AB Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Magle Chemoswed Holding AB's Days Payable falls into.
Magle Chemoswed Holding AB Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Magle Chemoswed Holding AB (OSTO:MAGLE) has a Days Payable of 438.76 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Magle Chemoswed Holding AB and its competitors. This is 80% above median its historical median of 243.23. Over the past decade, Magle Chemoswed Holding AB's Days Payable has ranged from 177.46 to 773.50. According to the industry distribution chart, Magle Chemoswed Holding AB ranks #214 out of 702 companies in the Biotechnology industry, placing it in the top 30.5%.
Is Magle Chemoswed Holding AB's Days Payable too high?
Magle Chemoswed Holding AB's current Days Payable of 438.76 is 80% above median its 10-year median of 243.23. Over the past 10 years, this metric has ranged from a low of 177.46 to a high of 773.50. The Biotechnology industry median Days Payable is 113.56. Magle Chemoswed Holding AB's value of 438.76 is 286.4% above this industry median. Based on the distribution chart, Magle Chemoswed Holding AB ranks #214 out of 702 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Magle Chemoswed Holding AB has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Magle Chemoswed Holding AB's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Magle Chemoswed Holding AB ranks #214 out of 702 companies for Days Payable. This puts Magle Chemoswed Holding AB in the upper half of its industry. The industry median Days Payable is 113.56. Magle Chemoswed Holding AB's value of 438.76 is 286.4% above this benchmark. Historically, Magle Chemoswed Holding AB's own Days Payable has ranged from 177.46 to 773.50 over the past decade. While the company's 10-year median is 243.23 vs. the industry median of 113.56, Magle Chemoswed Holding AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Magle Chemoswed Holding AB's current Days Payable of 438.76 is 286.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Magle Chemoswed Holding AB and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Magle Chemoswed Holding AB's current Days Payable is 438.76, which is 80% above median its own 10-year median of 243.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Magle Chemoswed Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Magle Chemoswed Holding AB (OSTO:MAGLE) is currently considered Possible Value Trap. The stock's GF Value™ is kr23.19, compared to a current price of kr1.00 — trading 95.7% below its estimated fair value. The current Days Payable is 438.76, which is 80% above median its 10-year median of 243.23 and 286.4% above the Biotechnology industry median of 113.56. Magle Chemoswed Holding AB's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Magle Chemoswed Holding AB (OSTO:MAGLE), the current Days Payable is 438.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Magle Chemoswed Holding AB (OSTO:MAGLE) Overvalued in 2026?
Based on GuruFocus' analysis, Magle Chemoswed Holding AB stock appears to be undervalued.
The current stock price of kr1.00 is trading 95.7% below its estimated GF Value™ of kr23.19.
GuruFocus considers Magle Chemoswed Holding AB to be Possible Value Trap.
Key valuation signals for OSTO:MAGLE:
Days Payable: 438.76 (80% above median its 10-year median of 243.23)
GF Value™: kr23.19 vs. price of kr1.00 (95.7% below fair value)
Industry Position: 286.4% above the Biotechnology median (#214 of 702)
No single metric tells the full story. See the OSTO:MAGLE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
38GF Score
Get the complete analysis for OSTO:MAGLE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:MAGLE has been successfully added to your 
